

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | angiotensin maturation (GO:0002003) | 5.69518564 |
| 2 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.21593148 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 4.54417396 |
| 4 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.47482576 |
| 5 | intestinal absorption (GO:0050892) | 4.40495866 |
| 6 | lipoprotein transport (GO:0042953) | 4.31145818 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.27722627 |
| 8 | diacylglycerol metabolic process (GO:0046339) | 4.13269401 |
| 9 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.11660920 |
| 10 | protein-lipid complex assembly (GO:0065005) | 4.11196660 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.06015657 |
| 12 | regulation of cellular extravasation (GO:0002691) | 4.01984069 |
| 13 | regulation of cholesterol esterification (GO:0010872) | 3.99753549 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.94694527 |
| 15 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86144302 |
| 16 | regulation of guanylate cyclase activity (GO:0031282) | 3.76666823 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.71233524 |
| 18 | negative regulation of cell killing (GO:0031342) | 3.56624297 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.56624297 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.56458319 |
| 21 | detection of bacterium (GO:0016045) | 3.53400721 |
| 22 | phospholipid efflux (GO:0033700) | 3.52638284 |
| 23 | NADH metabolic process (GO:0006734) | 3.52328226 |
| 24 | detection of other organism (GO:0098543) | 3.47235748 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.46341356 |
| 26 | low-density lipoprotein particle remodeling (GO:0034374) | 3.46268580 |
| 27 | epoxygenase P450 pathway (GO:0019373) | 3.30107818 |
| 28 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.28121298 |
| 29 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.28121298 |
| 30 | plasma lipoprotein particle organization (GO:0071827) | 3.24717890 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 3.23302018 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 3.23302018 |
| 33 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.23302018 |
| 34 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.23302018 |
| 35 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.23302018 |
| 36 | modulation by symbiont of host immune response (GO:0052553) | 3.23302018 |
| 37 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.21530491 |
| 38 | endocrine process (GO:0050886) | 3.21530491 |
| 39 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.21530491 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19521066 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 3.19521066 |
| 42 | macromolecular complex remodeling (GO:0034367) | 3.19521066 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.17828806 |
| 44 | positive regulation of respiratory burst (GO:0060267) | 3.13678538 |
| 45 | peptide catabolic process (GO:0043171) | 3.10497378 |
| 46 | protein-lipid complex subunit organization (GO:0071825) | 3.09003519 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.08365130 |
| 48 | glycosphingolipid catabolic process (GO:0046479) | 3.04707512 |
| 49 | high-density lipoprotein particle remodeling (GO:0034375) | 3.03538671 |
| 50 | lipoprotein metabolic process (GO:0042157) | 3.01285158 |
| 51 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.01213173 |
| 52 | cholesterol efflux (GO:0033344) | 3.01189633 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 2.99699867 |
| 54 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.94340272 |
| 55 | hormone catabolic process (GO:0042447) | 2.92877087 |
| 56 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.91171709 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 2.87448882 |
| 58 | glycolipid catabolic process (GO:0019377) | 2.87336451 |
| 59 | response to peptidoglycan (GO:0032494) | 2.86579551 |
| 60 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.83316561 |
| 61 | fructose metabolic process (GO:0006000) | 2.82093385 |
| 62 | regulation of systemic arterial blood pressure (GO:0003073) | 2.79911492 |
| 63 | GDP-mannose metabolic process (GO:0019673) | 2.76428220 |
| 64 | bile acid and bile salt transport (GO:0015721) | 2.73797174 |
| 65 | regulation of mast cell degranulation (GO:0043304) | 2.69591534 |
| 66 | leukotriene metabolic process (GO:0006691) | 2.66650691 |
| 67 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.66428063 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66190090 |
| 69 | detection of external biotic stimulus (GO:0098581) | 2.65359122 |
| 70 | B cell mediated immunity (GO:0019724) | 2.64775320 |
| 71 | macrophage activation involved in immune response (GO:0002281) | 2.63238980 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 2.62758484 |
| 73 | urea cycle (GO:0000050) | 2.61554911 |
| 74 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60538734 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.58718694 |
| 76 | drug transport (GO:0015893) | 2.58011035 |
| 77 | neutrophil activation (GO:0042119) | 2.57136710 |
| 78 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.57070366 |
| 79 | reverse cholesterol transport (GO:0043691) | 2.56328102 |
| 80 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.55688949 |
| 81 | respiratory burst (GO:0045730) | 2.55352997 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55126491 |
| 83 | flavonoid metabolic process (GO:0009812) | 2.54250594 |
| 84 | regulation of cholesterol homeostasis (GO:2000188) | 2.53531546 |
| 85 | regulation of superoxide anion generation (GO:0032928) | 2.52503054 |
| 86 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.50673090 |
| 87 | uronic acid metabolic process (GO:0006063) | 2.50109394 |
| 88 | glucuronate metabolic process (GO:0019585) | 2.50109394 |
| 89 | cholesterol homeostasis (GO:0042632) | 2.48015374 |
| 90 | cellular glucuronidation (GO:0052695) | 2.47077612 |
| 91 | regulation of vitamin metabolic process (GO:0030656) | 2.47063997 |
| 92 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.46143594 |
| 93 | ceramide catabolic process (GO:0046514) | 2.45987017 |
| 94 | plasma lipoprotein particle clearance (GO:0034381) | 2.44672627 |
| 95 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44549912 |
| 96 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43503854 |
| 97 | sterol homeostasis (GO:0055092) | 2.43005021 |
| 98 | urea metabolic process (GO:0019627) | 2.42940760 |
| 99 | drug metabolic process (GO:0017144) | 2.40930026 |
| 100 | low-density lipoprotein particle clearance (GO:0034383) | 2.39739511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.94763577 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.84575599 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.75170767 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.43210081 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.05527789 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76806365 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47463908 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44876543 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25557793 |
| 10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.23766321 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.18623285 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.15724038 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13041192 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05193451 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.02501720 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94514660 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93645836 |
| 18 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.88018142 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87219775 |
| 20 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.86827260 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86682554 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.85795743 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.83679383 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.80276186 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.79919636 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75878238 |
| 27 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.73760753 |
| 28 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73731163 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72971592 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66454618 |
| 31 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.63523279 |
| 32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.63460607 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63411036 |
| 34 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.61579031 |
| 35 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.57873867 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.57084301 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56714147 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51394220 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.49103395 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47088838 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.46098037 |
| 42 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45653172 |
| 43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44974124 |
| 44 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44610967 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.43800384 |
| 46 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40809365 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40431929 |
| 48 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36190094 |
| 49 | MAF_26560356_Chip-Seq_TH1_Human | 1.35178346 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34294260 |
| 51 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34169136 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.33206095 |
| 53 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32829104 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.31815087 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30296341 |
| 56 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30056632 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29235560 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.28464199 |
| 59 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.28378922 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27455716 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24724229 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24076280 |
| 63 | SA1_27219007_Chip-Seq_Bcells_Human | 1.22155473 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20716812 |
| 65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.20242903 |
| 66 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20113390 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17943851 |
| 68 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17905172 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17652504 |
| 70 | MYB_26560356_Chip-Seq_TH1_Human | 1.17514284 |
| 71 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17475989 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.16974424 |
| 73 | P68_20966046_ChIP-Seq_HELA_Human | 1.16899358 |
| 74 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.16376117 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16169823 |
| 76 | P300_27268052_Chip-Seq_Bcells_Human | 1.15607240 |
| 77 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14720646 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.14437708 |
| 79 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14386963 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13446500 |
| 81 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.13087863 |
| 82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.12779728 |
| 83 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11022196 |
| 84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10040042 |
| 85 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09147307 |
| 86 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.09013164 |
| 87 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08323095 |
| 88 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.05270519 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03699629 |
| 90 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.03112138 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 1.03056966 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.02705876 |
| 93 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.01848881 |
| 94 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00887028 |
| 95 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.99795721 |
| 96 | MYC_22102868_ChIP-Seq_BL_Human | 0.98984786 |
| 97 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.98850169 |
| 98 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98497962 |
| 99 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.98447437 |
| 100 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96825443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.36472545 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.77811331 |
| 3 | MP0005365_abnormal_bile_salt | 3.57159890 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.22118819 |
| 5 | MP0003724_increased_susceptibility_to | 3.15853434 |
| 6 | MP0009840_abnormal_foam_cell | 3.12379097 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.09625529 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.03596813 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.89240036 |
| 10 | MP0003436_decreased_susceptibility_to | 2.70202537 |
| 11 | MP0010155_abnormal_intestine_physiology | 2.39641395 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.37489354 |
| 13 | MP0003303_peritoneal_inflammation | 2.27059491 |
| 14 | MP0009785_altered_susceptibility_to | 2.19917262 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.14408305 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13477191 |
| 17 | MP0004264_abnormal_extraembryonic_tissu | 2.06557021 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.05917661 |
| 19 | MP0005025_abnormal_response_to | 2.04576819 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.01441523 |
| 21 | MP0003866_abnormal_defecation | 2.01394991 |
| 22 | MP0002419_abnormal_innate_immunity | 1.89082925 |
| 23 | MP0006082_CNS_inflammation | 1.87517154 |
| 24 | MP0001800_abnormal_humoral_immune | 1.84245599 |
| 25 | MP0005671_abnormal_response_to | 1.83736886 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.83018714 |
| 27 | MP0001790_abnormal_immune_system | 1.80878949 |
| 28 | MP0005387_immune_system_phenotype | 1.80878949 |
| 29 | MP0000685_abnormal_immune_system | 1.79337122 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.77477046 |
| 31 | MP0004147_increased_porphyrin_level | 1.71420249 |
| 32 | MP0005451_abnormal_body_composition | 1.68873937 |
| 33 | MP0005464_abnormal_platelet_physiology | 1.68373528 |
| 34 | MP0009764_decreased_sensitivity_to | 1.64432321 |
| 35 | MP0002723_abnormal_immune_serum | 1.61666044 |
| 36 | MP0002132_abnormal_respiratory_system | 1.59852431 |
| 37 | MP0002452_abnormal_antigen_presenting | 1.56017762 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.55273246 |
| 39 | MP0001533_abnormal_skeleton_physiology | 1.54418091 |
| 40 | MP0008469_abnormal_protein_level | 1.54275019 |
| 41 | MP0001845_abnormal_inflammatory_respons | 1.54013030 |
| 42 | MP0001819_abnormal_immune_cell | 1.46566744 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.46142731 |
| 44 | MP0001873_stomach_inflammation | 1.44999470 |
| 45 | MP0009643_abnormal_urine_homeostasis | 1.40433443 |
| 46 | MP0003252_abnormal_bile_duct | 1.40123029 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.36799269 |
| 48 | MP0005166_decreased_susceptibility_to | 1.34886557 |
| 49 | MP0000609_abnormal_liver_physiology | 1.33936609 |
| 50 | MP0001663_abnormal_digestive_system | 1.31208890 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.30818629 |
| 52 | MP0002118_abnormal_lipid_homeostasis | 1.24032650 |
| 53 | MP0005332_abnormal_amino_acid | 1.23595997 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.23271891 |
| 55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21055742 |
| 56 | MP0005319_abnormal_enzyme/_coenzyme | 1.20457716 |
| 57 | MP0003300_gastrointestinal_ulcer | 1.18444094 |
| 58 | MP0001764_abnormal_homeostasis | 1.18103494 |
| 59 | MP0008260_abnormal_autophagy | 1.17921131 |
| 60 | MP0000490_abnormal_crypts_of | 1.16128875 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.15983235 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.14803823 |
| 63 | MP0004947_skin_inflammation | 1.12320116 |
| 64 | MP0000858_altered_metastatic_potential | 1.08319306 |
| 65 | MP0005084_abnormal_gallbladder_morpholo | 1.08008481 |
| 66 | MP0000716_abnormal_immune_system | 1.05347892 |
| 67 | MP0001664_abnormal_digestion | 1.04174670 |
| 68 | MP0002405_respiratory_system_inflammati | 1.03053734 |
| 69 | MP0001765_abnormal_ion_homeostasis | 1.00309603 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.96649609 |
| 71 | MP0005670_abnormal_white_adipose | 0.94417058 |
| 72 | MP0003075_altered_response_to | 0.90855534 |
| 73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.90643386 |
| 74 | MP0002398_abnormal_bone_marrow | 0.90389795 |
| 75 | MP0008004_abnormal_stomach_pH | 0.90216304 |
| 76 | MP0000604_amyloidosis | 0.89295621 |
| 77 | MP0002429_abnormal_blood_cell | 0.88618897 |
| 78 | MP0003868_abnormal_feces_composition | 0.88376695 |
| 79 | MP0005381_digestive/alimentary_phenotyp | 0.87586497 |
| 80 | MP0000477_abnormal_intestine_morphology | 0.87336818 |
| 81 | MP0003763_abnormal_thymus_physiology | 0.87252606 |
| 82 | MP0001756_abnormal_urination | 0.87129550 |
| 83 | MP0003879_abnormal_hair_cell | 0.86359337 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.85599137 |
| 85 | MP0005410_abnormal_fertilization | 0.83645626 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.81393605 |
| 87 | MP0009115_abnormal_fat_cell | 0.81270672 |
| 88 | MP0005409_darkened_coat_color | 0.81267534 |
| 89 | MP0003011_delayed_dark_adaptation | 0.79822256 |
| 90 | MP0002876_abnormal_thyroid_physiology | 0.79696906 |
| 91 | MP0002722_abnormal_immune_system | 0.78722521 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.78477252 |
| 93 | MP0002396_abnormal_hematopoietic_system | 0.77143563 |
| 94 | MP0005448_abnormal_energy_balance | 0.76487928 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.74835041 |
| 96 | MP0005535_abnormal_body_temperature | 0.74102767 |
| 97 | MP0001986_abnormal_taste_sensitivity | 0.73431367 |
| 98 | MP0000343_altered_response_to | 0.73012705 |
| 99 | MP0005310_abnormal_salivary_gland | 0.72422346 |
| 100 | MP0003195_calcinosis | 0.72035904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.99348246 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 4.42860940 |
| 3 | Malnutrition (HP:0004395) | 4.14216890 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.04968190 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 3.91740634 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.56559155 |
| 7 | Myositis (HP:0100614) | 3.50292994 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.44115242 |
| 9 | Hydroxyprolinuria (HP:0003080) | 3.43196304 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 3.43196304 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.40049557 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.37077669 |
| 13 | Hemorrhage of the eye (HP:0011885) | 3.28847388 |
| 14 | Amyloidosis (HP:0011034) | 3.27557437 |
| 15 | Orchitis (HP:0100796) | 3.22734711 |
| 16 | Chronic diarrhea (HP:0002028) | 3.15633416 |
| 17 | Xanthomatosis (HP:0000991) | 3.13296429 |
| 18 | Acanthocytosis (HP:0001927) | 3.11009278 |
| 19 | Glomerulonephritis (HP:0000099) | 3.06695583 |
| 20 | Widely patent fontanelles and sutures (HP:0004492) | 3.02416940 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.99285294 |
| 22 | Petechiae (HP:0000967) | 2.95269920 |
| 23 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.92473452 |
| 24 | Nausea (HP:0002018) | 2.84956773 |
| 25 | Optic neuritis (HP:0100653) | 2.80892807 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 2.80892807 |
| 27 | Ileus (HP:0002595) | 2.78233928 |
| 28 | Stomatitis (HP:0010280) | 2.73543015 |
| 29 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70744226 |
| 30 | Obstructive lung disease (HP:0006536) | 2.70744226 |
| 31 | Fat malabsorption (HP:0002630) | 2.70131299 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.68638426 |
| 33 | Pigmentary retinal degeneration (HP:0001146) | 2.67030885 |
| 34 | Deep venous thrombosis (HP:0002625) | 2.65982601 |
| 35 | Vasculitis (HP:0002633) | 2.59438904 |
| 36 | Complement deficiency (HP:0004431) | 2.54091199 |
| 37 | Vacuolated lymphocytes (HP:0001922) | 2.51544661 |
| 38 | Encephalitis (HP:0002383) | 2.50889282 |
| 39 | Pustule (HP:0200039) | 2.48374106 |
| 40 | Abnormality of complement system (HP:0005339) | 2.46657225 |
| 41 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.46067294 |
| 42 | Purpura (HP:0000979) | 2.42282816 |
| 43 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40770946 |
| 44 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40770946 |
| 45 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40770946 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.33581046 |
| 47 | Gingival bleeding (HP:0000225) | 2.33311278 |
| 48 | Increased serum ferritin (HP:0003281) | 2.31984594 |
| 49 | Alkalosis (HP:0001948) | 2.30262989 |
| 50 | Recurrent skin infections (HP:0001581) | 2.29608386 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.28775595 |
| 52 | Recurrent fungal infections (HP:0002841) | 2.27384631 |
| 53 | Decreased circulating renin level (HP:0003351) | 2.26368698 |
| 54 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25676545 |
| 55 | Meningitis (HP:0001287) | 2.23939441 |
| 56 | Hypochromic anemia (HP:0001931) | 2.22625343 |
| 57 | Abnormality of iron homeostasis (HP:0011031) | 2.21307170 |
| 58 | Urticaria (HP:0001025) | 2.20712096 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.20388446 |
| 60 | Episodic fever (HP:0001954) | 2.20266821 |
| 61 | Increased cerebral lipofuscin (HP:0011813) | 2.20183575 |
| 62 | Hyperammonemia (HP:0001987) | 2.19071053 |
| 63 | Hypophosphatemia (HP:0002148) | 2.17816673 |
| 64 | Gingivitis (HP:0000230) | 2.17476733 |
| 65 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.16617307 |
| 66 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15399697 |
| 67 | Joint hemorrhage (HP:0005261) | 2.12598875 |
| 68 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.11185941 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09185886 |
| 70 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08650373 |
| 71 | Mucopolysacchariduria (HP:0008155) | 2.08650373 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.08604068 |
| 73 | Glycosuria (HP:0003076) | 2.08604068 |
| 74 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08205280 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08205280 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08205280 |
| 77 | Metabolic alkalosis (HP:0200114) | 2.06978198 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.04588742 |
| 79 | Abdominal distention (HP:0003270) | 2.00153979 |
| 80 | Hyperactive renin-angiotensin system (HP:0000841) | 2.00042891 |
| 81 | Hemoptysis (HP:0002105) | 1.96184950 |
| 82 | Skin rash (HP:0000988) | 1.95893812 |
| 83 | Epistaxis (HP:0000421) | 1.95759637 |
| 84 | Pulmonary infiltrates (HP:0002113) | 1.95203412 |
| 85 | Wide cranial sutures (HP:0010537) | 1.94215345 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 1.93664850 |
| 87 | Inflammation of the large intestine (HP:0002037) | 1.92002547 |
| 88 | Anorexia (HP:0002039) | 1.91986338 |
| 89 | Thin bony cortex (HP:0002753) | 1.91687735 |
| 90 | Keratoconjunctivitis (HP:0001096) | 1.90367741 |
| 91 | Abnormality of vitamin metabolism (HP:0100508) | 1.88515815 |
| 92 | Nephritis (HP:0000123) | 1.86292339 |
| 93 | Posterior subcapsular cataract (HP:0007787) | 1.85526434 |
| 94 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.84757656 |
| 95 | Growth hormone excess (HP:0000845) | 1.84282799 |
| 96 | Pancreatitis (HP:0001733) | 1.83890098 |
| 97 | Hyperglycinuria (HP:0003108) | 1.83853998 |
| 98 | Pulmonary embolism (HP:0002204) | 1.83390901 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.83118187 |
| 100 | Prolonged partial thromboplastin time (HP:0003645) | 1.82421297 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.02638985 |
| 2 | RIPK4 | 3.74941416 |
| 3 | ACVR1B | 3.17900860 |
| 4 | INSRR | 3.07954659 |
| 5 | MAP4K1 | 2.96749543 |
| 6 | TXK | 2.85199465 |
| 7 | TYK2 | 2.71474183 |
| 8 | GRK6 | 2.54172812 |
| 9 | BLK | 2.14819579 |
| 10 | IRAK4 | 2.12133367 |
| 11 | CSK | 2.08486959 |
| 12 | MAP2K3 | 1.98553829 |
| 13 | FES | 1.91871115 |
| 14 | KDR | 1.89368375 |
| 15 | PRKG2 | 1.88278761 |
| 16 | ZAP70 | 1.86511662 |
| 17 | MST1R | 1.85397769 |
| 18 | MATK | 1.76419002 |
| 19 | FGFR4 | 1.72595149 |
| 20 | TESK2 | 1.72026407 |
| 21 | TGFBR2 | 1.62587651 |
| 22 | TBK1 | 1.60778892 |
| 23 | SYK | 1.54289078 |
| 24 | MAP2K2 | 1.48959770 |
| 25 | BTK | 1.47424638 |
| 26 | MAP3K14 | 1.44155525 |
| 27 | LYN | 1.41818030 |
| 28 | MAP3K11 | 1.40204608 |
| 29 | PDK2 | 1.37989357 |
| 30 | MAP3K3 | 1.37074846 |
| 31 | MAP3K1 | 1.34742981 |
| 32 | PDPK1 | 1.34335026 |
| 33 | FGR | 1.33566692 |
| 34 | CSF1R | 1.26735231 |
| 35 | PDK1 | 1.23094676 |
| 36 | PRPF4B | 1.21832330 |
| 37 | JAK3 | 1.16526248 |
| 38 | TAOK3 | 1.09251250 |
| 39 | IKBKE | 1.08905972 |
| 40 | MARK3 | 1.08206730 |
| 41 | NME2 | 1.07746829 |
| 42 | IRAK3 | 1.06380227 |
| 43 | RIPK1 | 1.06354171 |
| 44 | TNK2 | 1.03874846 |
| 45 | ITK | 1.02606084 |
| 46 | IKBKB | 1.02135005 |
| 47 | LCK | 1.01380031 |
| 48 | JAK2 | 0.97742320 |
| 49 | MAP3K2 | 0.95558159 |
| 50 | MAPK11 | 0.94619379 |
| 51 | PTK6 | 0.93536897 |
| 52 | HCK | 0.91452336 |
| 53 | KIT | 0.88221235 |
| 54 | SIK3 | 0.86112952 |
| 55 | TEC | 0.84954377 |
| 56 | OXSR1 | 0.83107913 |
| 57 | BMPR2 | 0.81621497 |
| 58 | FGFR3 | 0.81176216 |
| 59 | MAP2K6 | 0.79603130 |
| 60 | CDC42BPA | 0.78967193 |
| 61 | SIK2 | 0.77247899 |
| 62 | MAP3K12 | 0.75190394 |
| 63 | TAOK1 | 0.74606243 |
| 64 | TRIB3 | 0.74559945 |
| 65 | KSR2 | 0.73203273 |
| 66 | PIK3CA | 0.73055421 |
| 67 | WNK4 | 0.70882064 |
| 68 | JAK1 | 0.70741239 |
| 69 | STK39 | 0.66798894 |
| 70 | NME1 | 0.66589950 |
| 71 | DYRK1B | 0.62698008 |
| 72 | PRKAA2 | 0.58792746 |
| 73 | EPHA2 | 0.58737935 |
| 74 | PRKCQ | 0.56808513 |
| 75 | EPHB1 | 0.56026456 |
| 76 | PINK1 | 0.54146788 |
| 77 | FYN | 0.53279589 |
| 78 | YES1 | 0.51799653 |
| 79 | TAOK2 | 0.50284600 |
| 80 | LRRK2 | 0.49811604 |
| 81 | STK10 | 0.48401463 |
| 82 | SMG1 | 0.48250366 |
| 83 | GRK7 | 0.47479658 |
| 84 | BMX | 0.47081015 |
| 85 | TLK1 | 0.43988701 |
| 86 | PIM2 | 0.43738562 |
| 87 | IGF1R | 0.40457381 |
| 88 | PIM1 | 0.38625569 |
| 89 | TESK1 | 0.38058503 |
| 90 | PRKACG | 0.37760322 |
| 91 | ABL2 | 0.37736063 |
| 92 | PRKCD | 0.37377822 |
| 93 | CDK19 | 0.37063259 |
| 94 | DAPK1 | 0.37010404 |
| 95 | GRK1 | 0.34160379 |
| 96 | MUSK | 0.33973217 |
| 97 | SRC | 0.33510544 |
| 98 | MAPKAPK2 | 0.33506561 |
| 99 | SIK1 | 0.33136953 |
| 100 | DDR2 | 0.33000731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.50069029 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.45668315 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.38492854 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81529550 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.42577035 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.35240480 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.22249340 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.21453165 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.16453840 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06669814 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.04280703 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.98045024 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89750723 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85331438 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.82781900 |
| 16 | Mineral absorption_Homo sapiens_hsa04978 | 1.79526208 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78957460 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78072252 |
| 19 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77550547 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.76571216 |
| 21 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69158779 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.65029764 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64384151 |
| 24 | Galactose metabolism_Homo sapiens_hsa00052 | 1.60912168 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60580618 |
| 26 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55527719 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.51575775 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.33829354 |
| 29 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.32566508 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32013299 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31113295 |
| 32 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.29737508 |
| 33 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27355712 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.25526456 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.25125002 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.24721317 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23564253 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21107261 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.19810915 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.17954821 |
| 41 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15695710 |
| 42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14335802 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.13039676 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.09701881 |
| 45 | Tuberculosis_Homo sapiens_hsa05152 | 1.08320058 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07852398 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.07427834 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05508080 |
| 49 | Pertussis_Homo sapiens_hsa05133 | 0.98537977 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.97710661 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97526047 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91205966 |
| 53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87900244 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87805553 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86673125 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.80540120 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80064894 |
| 58 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79113305 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77426801 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77188042 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.76627272 |
| 62 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.74519180 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73880938 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.73413885 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72740340 |
| 66 | Peroxisome_Homo sapiens_hsa04146 | 0.70309278 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69730584 |
| 68 | Influenza A_Homo sapiens_hsa05164 | 0.68711285 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64674882 |
| 70 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64267079 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62724650 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62179164 |
| 73 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59996690 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.59363351 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59242812 |
| 76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.57789624 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53194721 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.52387704 |
| 79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51136937 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50406691 |
| 81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.49180035 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.48440318 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.43744478 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43744055 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42987811 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42930009 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40649042 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40319077 |
| 89 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39226755 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.39141251 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39050493 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39018677 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38192339 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.37913848 |
| 95 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37202229 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.37070179 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36967197 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35796625 |
| 99 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35603691 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35128717 |

